T Cells Going Innate.
Authors:
Journal: Trends in immunology
Publication Type: Journal Article
Date: 2016
DOI: NIHMS801918
ID: 27402226
Abstract
Natural killer (NK) cell receptors (NKRs) play a crucial role in the homeostasis of antigen-experienced T cells. Indeed, prolonged antigen stimulation may induce changes in the receptor repertoire of T cells to a profile that features NKRs. Chronic antigen exposure, at the same time, has been shown to trigger the loss of costimulatory CD28 molecules with recently reported intensified antigen thresholds of antigen-experienced CD8(+) T cells. In transplantation, NKRs have been shown to assist allograft rejection in a CD28-independent fashion. We discuss here a role for CD28-negative T cells that have acquired the competency of the NKR machinery, potentially promoting allorecognition either through T cell receptor (TCR) crossreactivity or independently from TCR recognition. Collectively, NKRs can bring about innate-like T cells by providing alternative costimulatory pathways that gain relevance in chronic inflammation, potentially leading to resistance to CD28-targeting immunosuppressants.
Chemical List
- Antigens|||CD28 Antigens|||Receptors, Antigen, T-Cell|||Receptors, Natural Killer Cell
Reference List
- Ljunggren HG, Kärre K. In search of the “missing self”: MHC molecules and NK cell recognition. Immunol Today. 1990;11:237–44.|||Bauer S, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 1999;285:727–9.|||Chen L, Flies DB. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol. 2013;13:227–42.|||Janeway CA. Approaching the Asymptote? Evolution and Revolution in Immunology. Cold Spring Harb Symp Quant Biol. 1989;54:1–13.|||O’Leary JG, et al. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol. 2006;7:507–16.|||Vivier E, et al. Innate or adaptive immunity? The example of natural killer cells. Science. 2011;331:44–9.|||Wencker M, et al. Innate-like T cells straddle innate and adaptive immunity by altering antigen-receptor responsiveness. Nat Immunol. 2014;15:80–7.|||Bedoui S, et al. Parallels and differences between innate and adaptive lymphocytes. Nat Immunol. 2016;17:490–4.|||Kastenmüller W, et al. A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell. 2012;150:1235–48.|||Jabri B, et al. TCR specificity dictates CD94/NKG2A expression by human CTL. Immunity. 2002;17:487–99.|||Strid J, et al. Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis. Nat Immunol. 2008;9:146–154.|||Soudja SM, et al. Inflammatory monocytes activate memory CD8(+) T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion. Immunity. 2012;37:549–62.|||Chu T, et al. Bystander-activated memory CD8 T cells control early pathogen load in an innate-like, NKG2D-dependent manner. Cell Rep. 2013;3:701–8.|||Ruiz AL, et al. NK1.1+ CD8+ T cells escape TGF-β control and contribute to early microbial pathogen response. Nat Commun. 2014;5:5150.|||McQueen B, et al. NKG2D and CD28 receptors differentially activate mTOR to alter murine effector CD8(+) T cell differentiation. Immunology. 2015 DOI: 10.1111/imm.12563.|||Zloza A, et al. NKG2D signaling on CD8+ T cells represses T-bet and rescues CD4-unhelped CD8+ T cell memory recall but not effector responses. Nat Med. 2012;18:422–8.|||Alves NL, et al. IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro. Blood. 2003;102:2541–6.|||Richer MJ, et al. Inflammatory IL-15 is required for optimal memory T cell responses. J Clin Invest. 2015;125:3477–90.|||Marçais A, et al. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat Immunol. 2014;15:749–57.|||Vallejo AN, et al. Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence. J Immunol. 1999;162:6572–9.|||Mehlhop-Williams ER, Bevan MJ. Memory CD8+ T cells exhibit increased antigen threshold requirements for recall proliferation. J Exp Med. 2014;211:345–56.|||Assarsson E, et al. CD8+ T Cells Rapidly Acquire NK1.1 and NK Cell-Associated Molecules Upon Stimulation In Vitro and In Vivo. J Immunol. 2000;165:3673–3679.|||McMahon CW, et al. Viral and bacterial infections induce expression of multiple NK cell receptors in responding CD8(+) T cells. J Immunol. 2002;169:1444–52.|||Tarazona R, et al. Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech Ageing Dev. 2000;121:77–88.|||Peralbo E, et al. Invariant NKT and NKT-like lymphocytes: two different T cell subsets that are differentially affected by ageing. Exp Gerontol. 2007;42:703–8.|||van Stijn A, et al. Human Cytomegalovirus Infection Induces a Rapid and Sustained Change in the Expression of NK Cell Receptors on CD8+ T Cells. J Immunol. 2008;180:4550–4560.|||Suessmuth Y, et al. CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire. Blood. 2015;125:3835–50.|||Hassouneh F, et al. Effect of age and latent CMV infection on CD8+ CD56+ T cells (NKT-like) frequency and functionality. Mech Ageing Dev. 2016 DOI: 10.1016/j.mad.2015.12.003.|||Strauss-Albee DM, et al. Coordinated regulation of NK receptor expression in the maturing human immune system. J Immunol. 2014;193:4871–9.|||Espinosa J, et al. CD57(+) CD4 T cells underlie belatacept-resistant allograft rejection. Am J Transplant. 2015 DOI: 10.1111/ajt.13613.|||Yap M, et al. Expansion of highly differentiated cytotoxic terminally differentiated effector memory CD8+ T cells in a subset of clinically stable kidney transplant recipients: a potential marker for late graft dysfunction. J Am Soc Nephrol. 2014;25:1856–68.|||Bottomley MJ, et al. CD8+ Immunosenescence Predicts Post-Transplant Cutaneous Squamous Cell Carcinoma in High-Risk Patients. J Am Soc Nephrol. 2015 DOI: 10.1681/ASN.2015030250.|||Li XC, et al. Memory T cells in transplantation - progress and challenges. Curr Opin Organ Transplant. 2013;18:387–92.|||Chalasani G, et al. Recall and propagation of allospecific memory T cells independent of secondary lymphoid organs. Proc Natl Acad Sci U S A. 2002;99:6175–80.|||Hidalgo LG, et al. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant. 2010;10:1812–22.|||Hirohashi T, et al. A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody. Am J Transplant. 2012;12:313–21.|||Venner JM, et al. The molecular landscape of antibody-mediated kidney transplant rejection: evidence for NK involvement through CD16a Fc receptors. Am J Transplant. 2015;15:1336–48.|||Zhang Z-X, et al. Natural Killer Cells Mediate Long-term Kidney Allograft Injury. Transplantation. 2015;99:916–24.|||Zhang Z-X, et al. Natural Killer Cells Play a Critical Role in Cardiac Allograft Vasculopathy in an Interleukin-6–Dependent Manner. Transplantation. 2014;98:1029–1039.|||Li L, et al. A common peripheral blood gene set for diagnosis of operational tolerance in pediatric and adult liver transplantation. Am J Transplant. 2012;12:1218–28.|||Beilke JN, et al. NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Nat Med. 2005;11:1059–65.|||Yu G, et al. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med. 2006;203:1851–8.|||van der Touw W, et al. NK cells are required for costimulatory blockade induced tolerance to vascularized allografts. Transplantation. 2012;94:575–84.|||Lantow M, et al. CD27low natural killer cells prolong allograft survival in mice by controlling alloreactive CD8+ T cells in a T-bet-dependent manner. Transplantation. 2015;99:391–9.|||Allard M, et al. HLA-E-Restricted Cross-Recognition of Allogeneic Endothelial Cells by CMV-Associated CD8 T Cells: A Potential Risk Factor following Transplantation. PLoS One. 2012;7:e50951.|||Romagnani C, et al. Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells. Proc Natl Acad Sci U S A. 2002;99:11328–33.|||Shabir S, et al. CMV-associated CD4(+) CD28(null) cells in NKG2D-dependent glomerular endothelial injury and kidney allograft dysfunction. Am J Transplant. 2015 DOI: 10.1111/ajt.13614.|||Maier S, et al. Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28−/− mice. Nat Med. 2001;7:557–62.|||Kim J, et al. The activating immunoreceptor NKG2D and its ligands are involved in allograft transplant rejection. J Immunol. 2007;179:6416–20.|||Venner JM, et al. Molecular landscape of T cell-mediated rejection in human kidney transplants: prominence of CTLA4 and PD ligands. Am J Transplant. 2014;14:2565–76.|||Chen G, et al. T cell aging: a review of the transcriptional changes determined from genome-wide analysis. Front Immunol. 2013;4:121.|||Mou D, et al. CD28 negative T cells: is their loss our gain? Am J Transplant. 2014;14:2460–6.|||Freeman BE, et al. Regulation of innate CD8+ T-cell activation mediated by cytokines. Proc Natl Acad Sci U S A. 2012;109:9971–6.|||Suarez-Ramirez JE, et al. CD8 T cells in innate immune responses: using STAT4-dependent but antigen-independent pathways to gamma interferon during viral infection. MBio. 2014;5:e01978–14.|||Holzapfel KL, et al. Antigen-dependent versus -independent activation of invariant NKT cells during infection. J Immunol. 2014;192:5490–8.|||Wang X, et al. Human invariant natural killer T cells acquire transient innate responsiveness via histone H4 acetylation induced by weak TCR stimulation. J Exp Med. 2012;209:987–1000.|||Vahl JC, et al. NKT cell-TCR expression activates conventional T cells in vivo, but is largely dispensable for mature NKT cell biology. PLoS Biol. 2013;11:e1001589.|||Boyman O, et al. Homeostatic maintenance of T cells and natural killer cells. Cell Mol Life Sci. 2012;69:1597–608.|||Lafferty KJ, Cunningham AJ. A new analysis of allogeneic interactions. Aust J Exp Biol Med Sci. 1975;53:27–42.|||Kirchhoff S, et al. TCR-mediated up-regulation of c-FLIPshort correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity. J Immunol. 2000;165:6293–300.|||McNerney ME, et al. Role of natural killer cell subsets in cardiac allograft rejection. Am J Transplant. 2006;6:505–13.|||Szot GL, et al. Different mechanisms of cardiac allograft rejection in wildtype and CD28-deficient mice. Am J Transplant. 2001;1:38–46.|||Zhang Z-X, et al. NK cells induce apoptosis in tubular epithelial cells and contribute to renal ischemia-reperfusion injury. J Immunol. 2008;181:7489–98.|||Markiewicz MA, et al. RAE1ε ligand expressed on pancreatic islets recruits NKG2D receptor-expressing cytotoxic T cells independent of T cell receptor recognition. Immunity. 2012;36:132–41.|||D’Addio F, et al. CD160Ig fusion protein targets a novel costimulatory pathway and prolongs allograft survival. PLoS One. 2013;8:e60391.|||Agrawal S, et al. Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells. J Immunol. 1999;162:1223–6.|||Cai G, et al. CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat Immunol. 2008;9:176–85.|||Tu TC, et al. CD160 is essential for NK-mediated IFN-γ production. J Exp Med. 2015;212:415–429.|||Vincenti F, et al. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study) Am J Transplant. 2010;10:535–46.|||Liu D, et al. 2B4 (CD244) induced by selective CD28 blockade functionally regulates allograft-specific CD8+ T cell responses. J Exp Med. 2014;211:297–311.|||Nakajima H, et al. Activating interactions in human NK cell recognition: the role of 2B4-CD48. Eur J Immunol. 1999;29:1676–83.|||Speiser DE, et al. The Activatory Receptor 2B4 Is Expressed In Vivo by Human CD8+ Effector T Cells. J Immunol. 2001;167:6165–6170.|||Waggoner SN, Kumar V. Evolving role of 2B4/CD244 in T and NK cell responses during virus infection. Front Immunol. 2012;3:377.|||Snyder MR, et al. Formation of the Killer Ig-Like Receptor Repertoire on CD4+CD28null T Cells. J Immunol. 2002;168:3839–3846.|||Fasth AER, et al. Activating NK-cell receptors co-stimulate CD4(+)CD28(−) T cells in patients with rheumatoid arthritis. Eur J Immunol. 2010;40:378–87.|||Nakajima T, et al. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation. 2002;105:570–5.|||Zal B, et al. Differential pathways govern CD4+ CD28− T cell proinflammatory and effector responses in patients with coronary artery disease. J Immunol. 2008;181:5233–41.|||Sáez-Borderías A, et al. Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus. Eur J Immunol. 2006;36:3198–206.|||Broux B, et al. IL-15 amplifies the pathogenic properties of CD4+CD28− T cells in multiple sclerosis. J Immunol. 2015;194:2099–109.|||Casado JG, et al. CD8 T cells expressing NK associated receptors are increased in melanoma patients and display an effector phenotype. Cancer Immunol Immunother. 2005;54:1162–71.|||Costello RT, et al. A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand. Leukemia. 2002;16:855–60.|||Roberts AI, et al. NKG2D receptors induced by IL-15 costimulate CD28− negative effector CTL in the tissue microenvironment. J Immunol. 2001;167:5527–30.|||Meresse B, et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity. 2004;21:357–66.|||von Geldern M, et al. TCR-independent cytokine stimulation induces non-MHC-restricted T cell activity and is negatively regulated by HLA class I. Eur J Immunol. 2006;36:2347–58.|||Kuylenstierna C, et al. NKG2D performs two functions in invariant NKT cells: direct TCR-independent activation of NK-like cytolysis and co-stimulation of activation by CD1d. Eur J Immunol. 2011;41:1913–23.|||Ibegbu CC, et al. Expression of killer cell lectin-like receptor G1 on antigen-specific human CD8+ T lymphocytes during active, latent, and resolved infection and its relation with CD57. J Immunol. 2005;174:6088–94.|||Henson SM, et al. KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells. Blood. 2009;113:6619–28.|||Li XC, et al. Costimulatory pathways in transplantation: challenges and new developments. Immunol Rev. 2009;229:271–293.|||Xu H, et al. The allo- and viral-specific immunosuppressive effect of belatacept, but not tacrolimus, attenuates with progressive T cell maturation. Am J Transplant. 2014;14:319–32.|||Traitanon O, et al. IL-15 induces alloreactive CD28(−) memory CD8 T cell proliferation and CTLA4-Ig resistant memory CD8 T cell activation. Am J Transplant. 2014;14:1277–89.|||Mou D, et al. Viral-induced CD28 loss evokes costimulation independent alloimmunity. J Surg Res. 2015;196:241–6.|||Williams MA, et al. Characterization of Virus-Mediated Inhibition of Mixed Chimerism and Allospecific Tolerance. J Immunol. 2001;167:4987–4995.|||Hoffmann U, et al. NK Cells of Kidney Transplant Recipients Display an Activated Phenotype that Is Influenced by Immunosuppression and Pathological Staging. PLoS One. 2015;10:e0132484.|||Demmers MWHJ, et al. Substantial proliferation of human renal tubular epithelial cell-reactive CD4+CD28null memory T cells, which is resistant to tacrolimus and everolimus. Transplantation. 2014;97:47–55.